Original Article

Apolipoprotein E knock-out mice are highly susceptible to endotoxemia and Klebsiella pneumoniae infection

Correspondence to: Anton F. H. Stalenhoef

Lipoproteins are able to neutralize bacterial lipopolysaccharide (LPS) and thereby inhibit the proinflammatory cytokine response. In a previous study, we demonstrated that hypercholesterolemic low density lipoprotein receptor knock-out (LDLr-/-) mice are protected against lethal endotoxemia and gram-negative infection. In the present study we investigated the susceptibility of apolipoprotein E knock-out mice (apoE-/-) to LPS and to Klebsiella pneumoniae. These mice have increased plasma lipoprotein concentrations in the very low density lipoprotein (VLDL)-sized fraction. Despite 8 -fold higher plasma cholesterol levels compared to controls, and in contrast to LDLr-/- mice, apoE-/- mice were significantly more susceptible to endotoxemia and to K. pneumoniae infection. Circulating TNF concentrations after intravenously injected LPS were 4 - to 5-fold higher in apoE-/- mice, whereas IL-1, IL-1ß, and IL-6 did not differ. This TNF response was not due to an increased cytokine production capacity of cells from apoE-/- mice, as ex vivo cytokine production in response to LPS did not differ between apoE-/- and control mice. The LPS-neutralizing capacity of apoE-/- plasma was significantly less than that of controls. Most likely, the absence of apoE itself in the knock-out mice explains the failure to neutralize LPS, despite the very high cholesterol concentrations.—de Bont, N., M. G. Netea, P. N. M. Demacker, I. Verschueren, B. J. Kullberg, K. W. van Dijk, J. W. M. van der Meer, and A. F. H. Stalenhoef. Apolipoprotein E knockout-mice are highly susceptible to endotoxemia and Klebsiella pneumoniae infection. J. Lipid Res. 1999. 40: 680–685.

Supplementary key words: lipopolysaccharide, tumor necrosis factor, apolipoprotein E, hypercholesterolemia, neutralization

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				L. Li, P. A. Thompson, and R. L. Kitchens Infection induces a positive acute phase apolipoprotein E response from a negative acute phase gene: role of hepatic LDL receptors J. Lipid Res., August 1, 2008; 49(8): 1782 - 1793. [Abstract] [Full Text] [PDF]

				J. F. P. Berbee, S. P. Mooijaart, A. J. M. de Craen, L. M. Havekes, D. van Heemst, P. C. N. Rensen, and R. G. J. Westendorp Plasma Apolipoprotein CI Protects Against Mortality From Infection in Old Age J. Gerontol. A Biol. Sci. Med. Sci., February 1, 2008; 63(2): 122 - 126. [Abstract] [Full Text] [PDF]

				P. V. Giannoudis, M. van Griensven, E. Tsiridis, and H. C. Pape The genetic predisposition to adverse outcome after trauma J Bone Joint Surg Br, October 1, 2007; 89-B(10): 1273 - 1279. [Abstract] [Full Text] [PDF]

				M. Hao, W. S. Head, S. C. Gunawardana, A. H. Hasty, and D. W. Piston Direct Effect of Cholesterol on Insulin Secretion: A Novel Mechanism for Pancreatic {beta}-Cell Dysfunction Diabetes, September 1, 2007; 56(9): 2328 - 2338. [Abstract] [Full Text] [PDF]

				A. T. Shamshiev, F. Ampenberger, B. Ernst, L. Rohrer, B. J. Marsland, and M. Kopf Dyslipidemia inhibits Toll-like receptor-induced activation of CD8{alpha}-negative dendritic cells and protective Th1 type immunity J. Exp. Med., February 19, 2007; 204(2): 441 - 452. [Abstract] [Full Text] [PDF]

				A. E. Mullick, A. F. Powers, R. S. Kota, S. D. Tetali, J. P. Eiserich, and J. C. Rutledge Apolipoprotein E3- and Nitric Oxide-Dependent Modulation of Endothelial Cell Inflammatory Responses Arterioscler. Thromb. Vasc. Biol., February 1, 2007; 27(2): 339 - 345. [Abstract] [Full Text] [PDF]

				R. B. Yates and M. Stafford-Smith The genetic determinants of renal impairment following cardiac surgery. Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2006; 10(4): 314 - 326. [Abstract] [PDF]

				H.-M. Cheon, S. W. Shin, G. Bian, J.-H. Park, and A. S. Raikhel Regulation of Lipid Metabolism Genes, Lipid Carrier Protein Lipophorin, and Its Receptor during Immune Challenge in the Mosquito Aedes aegypti J. Biol. Chem., March 31, 2006; 281(13): 8426 - 8435. [Abstract] [Full Text] [PDF]

				J. F.P. Berbee, L. M. Havekes, and P. C.N. Rensen Apolipoproteins modulate the inflammatory response to lipopolysaccharide Innate Immunity, April 1, 2005; 11(2): 97 - 103. [Abstract] [PDF]

				D. J. Grainger, J. Reckless, and E. McKilligin Apolipoprotein E Modulates Clearance of Apoptotic Bodies In Vitro and In Vivo, Resulting in a Systemic Proinflammatory State in Apolipoprotein E-Deficient Mice J. Immunol., November 15, 2004; 173(10): 6366 - 6375. [Abstract] [Full Text] [PDF]

				W. Khovidhunkit, M.-S. Kim, R. A. Memon, J. K. Shigenaga, A. H. Moser, K. R. Feingold, and C. Grunfeld Thematic review series: The Pathogenesis of Atherosclerosis. Effects of infection and inflammation on lipid and lipoprotein metabolism mechanisms and consequences to the host J. Lipid Res., July 1, 2004; 45(7): 1169 - 1196. [Abstract] [Full Text] [PDF]

				J. R. Lynch, W. Tang, H. Wang, M. P. Vitek, E. R. Bennett, P. M. Sullivan, D. S. Warner, and D. T. Laskowitz APOE Genotype and an ApoE-mimetic Peptide Modify the Systemic and Central Nervous System Inflammatory Response J. Biol. Chem., December 5, 2003; 278(49): 48529 - 48533. [Abstract] [Full Text] [PDF]

				S. Lanza-Jacoby, S. Miller, S. Jacob, D. Heumann, A. G. Minchenko, and J. T. Flynn Hyperlipoproteinemic low-density lipoprotein receptor-deficient mice are more susceptible to sepsis than corresponding wild-type mice Innate Immunity, December 1, 2003; 9(6): 341 - 347. [Abstract] [PDF]

				K. Christopher, T. F. Mueller, R. DeFina, Y. Liang, J. Zhang, R. Gentleman, and D. L. Perkins The graft response to transplantation: a gene expression profile analysis Physiol Genomics, September 29, 2003; 15(1): 52 - 64. [Abstract] [Full Text] [PDF]

				E. S. Van Amersfoort, T. J. C. Van Berkel, and J. Kuiper Receptors, Mediators, and Mechanisms Involved in Bacterial Sepsis and Septic Shock Clin. Microbiol. Rev., July 1, 2003; 16(3): 379 - 414. [Abstract] [Full Text] [PDF]

				H. W. Harris and F. B. Kasravi Lipoprotein-bound LPS induces cytokine tolerance in hepatocytes Innate Immunity, February 1, 2003; 9(1): 45 - 50. [Abstract] [PDF]

				S. Fazio, V. R. Babaev, M. E. Burleigh, A. S. Major, A. H. Hasty, and M. F. Linton Physiological expression of macrophage apoE in the artery wall reduces atherosclerosis in severely hyperlipidemic mice J. Lipid Res., October 1, 2002; 43(10): 1602 - 1609. [Abstract] [Full Text] [PDF]

				U. K. Misra, C. L. Adlakha, G. Gawdi, M. K. McMillian, S. V. Pizzo, and D. T. Laskowitz Apolipoprotein E and mimetic peptide initiate a calcium-dependent signaling response in macrophages J. Leukoc. Biol., October 1, 2001; 70(4): 677 - 683. [Abstract] [Full Text] [PDF]

				B. Ludewig, M. Jaggi, T. Dumrese, K. Brduscha-Riem, B. Odermatt, H. Hengartner, and R. M. Zinkernagel Hypercholesterolemia Exacerbates Virus-Induced Immunopathologic Liver Disease Via Suppression of Antiviral Cytotoxic T Cell Responses J. Immunol., March 1, 2001; 166(5): 3369 - 3376. [Abstract] [Full Text] [PDF]

				H. W. Harris, J. E. Gosnell, and Z. L. Kumwenda Review: The lipemia of sepsis: triglyceride-rich lipoproteins as agents of innate immunity Innate Immunity, December 1, 2000; 6(6): 421 - 430. [Abstract] [PDF]

				D. T. Laskowitz, D. M. Lee, D. Schmechel, and H. F. Staats Altered immune responses in apolipoprotein E-deficient mice J. Lipid Res., April 1, 2000; 41(4): 613 - 620. [Abstract] [Full Text]

				M. Van Oosten, P. C. N. Rensen, E. S. Van Amersfoort, M. Van Eck, A.-M. Van Dam, J. J. P. Breve, T. Vogel, A. Panet, T. J. C. Van Berkel, and J. Kuiper Apolipoprotein E Protects Against Bacterial Lipopolysaccharide-induced Lethality. A NEW THERAPEUTIC APPROACH TO TREAT GRAM-NEGATIVE SEPSIS J. Biol. Chem., March 16, 2001; 276(12): 8820 - 8824. [Abstract] [Full Text] [PDF]